Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Antiprotozoal Agents

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...

Drugs that Stabilize Microtubules

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Oxoaporphine Metal Complexes (Co<sup>II</sup>, Ni<sup>II</sup>, Zn<sup>II</sup>) with High Antitumor Activity by Inducing Mitochondria-Mediated Apoptosis and S-phase Arrest in HepG2.

Scientific reports·2017

Same author

Analysis of inequality in maternal and child health outcomes and mortality from 2000 to 2013 in China.

International journal for equity in health·2017

Same author

A Formulated TLR7/8 Agonist is a Flexible, Highly Potent and Effective Adjuvant for Pandemic Influenza Vaccines.

Scientific reports·2017

Same author

A New Viscous Cysteamine Eye Drops Treatment for Ophthalmic Cystinosis: An Open-Label Randomized Comparative Phase III Pivotal Study.

Investigative ophthalmology & visual science·2017

Same author

Prenatal exposure to β2-adrenoreceptor agonists and the risk of autism spectrum disorders in offspring.

Pharmacoepidemiology and drug safety·2017

Same author

Chemical constituents from the whole plants of Pilea cavaleriei Levl subsp. cavaleriei.

Fitoterapia·2017

Search research articles

Related Experiment Video

Updated: Jun 12, 2026

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

Progresses in TCM metal-based antitumour agents.

Zhen-Feng Chen¹, Hong Liang

¹Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources (Ministry of Education of China), School of Chemistry and Chemical Engineering, Guangxi Normal University, Guilin 541004, China. chenzfubc@yahoo.com

Anti-Cancer Agents in Medicinal Chemistry

|June 16, 2010

Summary

Traditional Chinese medicines (TCM) are emerging as anticancer agents and chemotherapy adjuvants. Hybrid TCM-metal complexes offer a promising strategy to overcome drug resistance and reduce side effects in cancer treatment.

More Related Videos

Preparation and Evaluation of 99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry

Preparation and Evaluation of ^99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry

Published on: February 4, 2017

Related Experiment Videos

Last Updated: Jun 12, 2026

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

Preparation and Evaluation of 99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry

Preparation and Evaluation of ^99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry

Published on: February 4, 2017

Area of Science:

Medicinal Chemistry
Pharmacology
Oncology

Background:

Traditional Chinese Medicines (TCM) show potential as anticancer agents and chemotherapy adjuvants.
Cisplatin is a widely used anticancer drug, but its efficacy is limited by side effects and resistance.
Developing novel platinum compounds with improved properties is crucial for cancer therapy.

Purpose of the Study:

To review the synthesis, structure, and anticancer activity of Traditional Chinese Medicine-based metal complexes.
To explore the potential of hybrid TCM-metal complexes as novel anticancer drugs.
To discuss strategies for overcoming multidrug resistance (MDR) using these agents.

Main Methods:

Literature review focusing on TCM-based metal complexes.
Analysis of synthesis, structural characteristics, and antitumour activity.
Examination of interactions with molecular targets.

Main Results:

Various TCM components (alkaloids, flavonoids, etc.) form metal-based antitumour agents.
These complexes exhibit promising anticancer activity and potential to mitigate chemotherapy side effects.
Hybrid TCM-metal complexes represent a novel approach to drug design.

Conclusions:

TCM-based metal complexes offer a promising avenue for developing new anticancer drugs.
These agents hold potential for enhancing chemotherapy efficacy and overcoming multidrug resistance.
Further research into hybrid TCM-metal complexes could revolutionize cancer treatment.